Police raid clinic to seize Maradona's complete medical records
People relax outside the Olivos Clinic, where soccer star Diego Maradona got surgery weeks before his 2020 passing, in Buenos Aires, Tuesday, May 6, 2025. (AP Photo/Rodrigo Abd) Updated [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year]
BUENOS AIRES, Argentina (AP) — Police carried out an overnight raid at a Buenos Aires health clinic to seize Diego Maradona's complete medical records following a court order during the trial of seven healthcare professionals accused of negligence in the former soccer star's death.
Pablo Dimitroff, the medical director at Los Olivos clinic, testified that Maradona underwent pre-surgical studies , and the operation was performed by a neurosurgeon at that center without complications.
Those studies were not included in Maradona's medical history and trial judges ordered the raid to seize all Maradona files dated between Nov. 3 and 11, 2020.
Maradona had surgery for a hematoma that formed between his skull and brain and stayed in intensive care at Olivos between Nov. 4-11. He then was sent recover to a private home where he died on Nov. 25 of 2020 at age 60.
The raid started around midnight and extended for four hours into Thursday morning.
Police said they secured about 275 pages of related archives and 547 emails exchanged between the medical professionals on trial.
The trial is set to continue Thursday.
___
AP soccer: https://apnews.com/hub/soccer
The Associated Press is an independent global news organization dedicated to factual reporting. Founded in 1846, AP today remains the most trusted source of fast, accurate, unbiased news in all formats and the essential provider of the technology and services vital to the news business. More than half the world's population sees AP journalism every day.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Entrepreneur
40 minutes ago
- Entrepreneur
Entrepreneur UK's London 100: Zonder Health Ltd
Zonder leverages AI to lighten provider workloads and deliver top-tier, cost-effective care Opinions expressed by Entrepreneur contributors are their own. You're reading Entrepreneur United Kingdom, an international franchise of Entrepreneur Media. Industry: Healthcare Last, but certainly not least, on the Entrepreneur UK London100 list is Zonder. Founded in 2024, Zonder leverages AI to lighten provider workloads and deliver top-tier, cost-effective care. With over a quarter of the UK population managing chronic conditions — accounting for half of all GP appointments and three-quarters of health spending — the demand on healthcare is immense. Amid a shortage of qualified professionals, Zonder steps in to manage these chronic conditions, easing the burden on primary care providers. By combining AI with a patient-centered approach, Zonder is revolutionising chronic disease management. Its innovative model integrates AI with human expertise, offering a scalable solution that improves patient outcomes while optimizing healthcare resources. The company stands as a beacon of innovation in healthcare, embodying the entrepreneurial spirit that drives progress in the city. Zonder's AI platform streamlines admin enhances patient communication, and meets QoF targets, freeing up providers to focus on delivering care.
Yahoo
2 hours ago
- Yahoo
Historic Aussie-first breakthrough in fight against condition impacting 40 million
In a groundbreaking leap forward in the global fight against HIV, researchers at Melbourne's world-renowned Doherty Institute have developed a revolutionary method that could one day pave the way for a cure, using the same mRNA technology that powered COVID-19 vaccines. This discovery gives fresh hope to the nearly 40 million people around the world living with HIV. While today's treatments can keep the virus under control, they can't remove it completely. That's because HIV hides in a type of white blood cell, staying asleep and undetectable. But if treatment stops, the virus can wake up and spread again. For decades, this hidden "reservoir" has been one of the biggest obstacles to finding a cure. Now, researchers believe they've found a way to reach these sleeping cells and wake the virus up in a safe and controlled way, while the patient is still on their usual medication. Speaking to Yahoo News Australia, Dr Michael Roche, a Senior Research Fellow at the Doherty Institute, explained how his team used mRNA wrapped inside tiny fat-like bubbles called lipid nanoparticles. These nanoparticles are designed to travel directly to infected cells. Once inside, the mRNA sends instructions to the cell to make a protein called Tat — a natural HIV protein that tells the virus it's time to wake up. "Tat is a protein that helps the virus 'wake up' when the virus wants to," Dr Roche said. "Here we are using Tat to wake the virus up when we want to." This process is often called the "shock and kill" strategy. The idea is to force the virus out of hiding while the patient is still on HIV medication, so the virus can't spread and can instead be targeted and destroyed by the immune system or future therapies. The discovery is still in early stages, but it's the first time mRNA has successfully reached and activated the HIV reservoir in a lab setting. The team's next step is to test the treatment in animal models to check if it's safe and if it works. "We are looking for two signals," Dr Roche said. "Firstly, safety. Secondly, efficacy — whether it can wake up dormant HIV in animals." These trials will take a few years. Only after passing those tests can human trials begin — first to ensure the treatment is safe, and then to test how well it works in people. A key advantage is that this therapy uses the same technology that powered the COVID-19 vaccine rollout. "Our therapeutic is based on the same technology — mRNA and lipid nanoparticles — used in the COVID vaccines," Dr Roche said. "The global rollout of these vaccines has shown that this approach can be scaled and distributed globally." He pointed to a new BioNTech mRNA facility in Rwanda, which is being set up to support production in areas with a high burden of HIV. The team is also focused on making sure the treatment, if successful, can be made affordable and accessible. "We are committed to ensuring any cures we develop are scalable, accessible and affordable," Dr Roche said. Aussies warned over widespread danger emerging in homes Concerning roadside find reveals dangerous trend landing Aussies in hospital Controversial 'alcohol alternative' coming to Woolworths this month In Australia, around 29,000 people are living with HIV. New infections have dropped over the past decade thanks to wider access to HIV prevention medication (PrEP), regular testing, and strong treatment programs. The country recorded its lowest number of new HIV cases in over 20 years in 2022. But some challenges remain. In 2023, there was a slight increase in new cases, mostly among people born overseas and those infected through heterosexual contact. Still, the long-term trend is positive, and now, with this research, a cure no longer feels out of reach. If successful, this approach could one day mean people living with HIV no longer need daily medication, and may even be able to live completely free of the virus. As the world watches closely, Australia's scientists are once again leading the charge. Do you have a story tip? Email: newsroomau@ You can also follow us on Facebook, Instagram, TikTok, Twitter and YouTube.
Forbes
4 hours ago
- Forbes
Time For Medicare Advantage Leaders—Including Me—To Eat Our Own Cooking
Dr. Oz just turned 65 and became a Medicare beneficiary. Everyone who operates a Medicare plan ... More should be required to be one as well. In every industry, the best leaders live the experience of the customer. Car executives drive their own vehicles. Airline leaders occasionally fly coach. Restauranteurs eat from their own kitchen. But in healthcare—and specifically in Medicare Advantage (MA), which now serves more than 30 million Americans—the leaders designing these plans rarely, if ever, use them themselves. This disconnect breeds an empathy gap between decision-makers and the seniors whose lives and well-being depend on these products. It's time to close that gap. As Dr. Mehmet Oz turns 65 and qualifies for Medicare, he is in a unique position to lead the charge in fixing this blind spot. But I'm not letting myself off the hook either. As a current CEO of company that sells Medicare Advantage plans, I am proposing a standard that would apply to me and every other leader in this space: if you run a Medicare Advantage plan—or sit on its executive team that runs these plans—you should be required to enroll in that plan. No carve-outs. No executive-only exemptions. No platinum side-door coverage. For those of us under 65, the proposal would also require a structural change: expanding Medicare eligibility to allow MA plan executives early, voluntary enrollment in their own plans. We should not be allowed to claim ignorance or detachment simply because of our age. I want to be clear: if such an early-enrollment window existed, I would enroll myself. I should have to live under the same benefit design, customer service, and network constraints as every other member. Leaders like me—and my peers across the industry—must eat our own cooking.A Modest But Necessary Reform The proposal is simple but powerful: 1. All managed care CEOs and executive teams must enroll in their own MA plan. 2. Congress and CMS should create a new category of Medicare eligibility that allows executives under 65 to voluntarily enroll in their own MA plans in a 'test user' capacity. This is the only way for leadership to truly understand the member experience. 3. No waivers, no special coverage allowances. The goal is to force leadership to live the true plan reality: the prior authorizations, the formularies, the network restrictions, the call centers, the appeals It Matters—for Me, and for the Industry I don't make this proposal lightly—because it would apply to me, too. If this became law or industry standard tomorrow, I would sign up. And I believe most honest leaders would welcome the clarity and accountability it would bring. Here's why it matters:- Operational Truth: You only truly understand the friction points—customer service delays, billing errors, prescription denials—if you live them yourself.- Accountability: Plan leaders would no longer tolerate broken systems they themselves have to endure.- Culture Change: A company where the C-suite shares the same risks and frustrations as members cannot help but become more consumer-focused.- Public Trust: Medicare Advantage is under increasing scrutiny from policymakers and the public. This move would send a clear, ethical signal: we stand behind what we sell.- Policy Innovation: The best ideas for simplifying prior authorization, improving networks, and reducing out-of-pocket costs would come not from distant consultants—but from firsthand More 'Not For Me' Products Too much of healthcare is designed by people who never have to use it. Too many decisions are made in corporate conference rooms far removed from the lived experience of real patients. If Medicare Advantage is the future of healthcare for seniors—as so many believe—its architects must also live that future. That includes Dr. Oz. That includes every MA CEO. And that includes me. It's time for all of us to eat our own cooking.
